Dave Weiner Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Dave Weiner

Stock Analyst at Piper Sandler

(4.59)
# 1423
Out of 5,506 analysts
8
Total ratings
Success rate
Average return

2 Stocks

Name Action PT Current % Upside Ratings Updated
MYGN Myriad Genetics
Maintains: Overweight
13 9
8.06 11.66% 3 May 15, 2025
LULU Lululemon Athletica
Upgrades: Buy
58 0
n/a n/a 5 Dec 14, 2017